{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:47:39Z","timestamp":1795085259851,"version":"4.10.2"},"reference-count":35,"publisher":"Portland Press Ltd.","issue":"6","license":[{"start":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T00:00:00Z","timestamp":1564099200000},"content-version":"vor","delay-in-days":220,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,12,21]]},"abstract":"<jats:p>Resistance to valproic acid (VPA), a first-line antiepileptic drug (AED), is occurring at an alarming rate, particularly in children. Signal nucleotide polymorphisms are considered crucial in this process. Therefore, we investigated whether the SCN1A polymorphism rs3812718 could be associated with VPA resistance. A total of 231 children with epilepsy who were solely administered VPA were enrolled. DNA was extracted from the peripheral blood samples and was genotyped by the Mass Array method. Furthermore, a meta-analysis was conducted between the drug responsive and resistant patients who were exposed to voltage-gated sodium channels. Results revealed that the TT genotype was associated with a higher risk of developing drug resistance (OR = 2.636, 95% CI 1.08\u20136.433, P = 0.033). After adjusting for the risk factors, a significant difference was still observed between the responsive and resistant groups (OR = 2.861, 95% CI 1.141\u20137.174, P = 0.025). Moreover, the recessive model was associated with a decreased drug resistance (OR = 0.402, 95% CI 0.167\u20130.968, P = 0.042) after correcting the risk factors. Meta-analysis of nine studies revealed similar results. In conclusion, our results proved that the rs3812718 TT genotype was associated with a high risk of developing drug resistance, and the recessive model could decrease the risk of VPA resistance.<\/jats:p>","DOI":"10.1042\/bsr20181654","type":"journal-article","created":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T11:55:17Z","timestamp":1541764517000},"update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Association between SCN1A polymorphism rs3812718 and valproic acid resistance in epilepsy children: a case\u2013control study and meta-analysis"],"prefix":"10.1042","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5352-9501","authenticated-orcid":false,"given":"Zhi\u00a0Jian","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Neurology, Fuzhou Neuropsychiatry Hospital, Fujian 350008, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fuzhou Neuropsychiatry Hospital, Fujian 350008, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai\u00a0Liang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fuzhou Neuropsychiatry Hospital, Fujian 350008, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin\u00a0Yan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fuzhou Neuropsychiatry Hospital, Fujian 350008, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duo","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fuzhou Neuropsychiatry Hospital, Fujian 350008, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen\u00a0Ting","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fuzhou Neuropsychiatry Hospital, Fujian 350008, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2018,12,18]]},"reference":[{"key":"2021111619233217400_B1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11910-016-0678-x","article-title":"Pharmacological treatment of drug-resistant epilepsy in adults: a practical guide","volume":"16","author":"Brodie","year":"2016","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"2021111619233217400_B2","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/jhg.2017.91","article-title":"The pharmacogenomics of valproic acid","volume":"62","author":"Zhu","year":"2017","journal-title":"J. Hum. Genet."},{"key":"2021111619233217400_B3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.seizure.2016.07.005","article-title":"The potential implication of SCN1A and CYP3A5 genetic variants on antiepileptic drug resistance among Egyptian epileptic children","volume":"41","author":"Abo","year":"2016","journal-title":"Seizure"},{"key":"2021111619233217400_B4","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/j.1528-1167.2011.03040.x","article-title":"SCN1A splice variants exhibit divergent sensitivity to commonly used antiepileptic drugs","volume":"52","author":"Thompson","year":"2011","journal-title":"Epilepsia"},{"key":"2021111619233217400_B5","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1086\/516650","article-title":"Nova2 interacts with a cis-acting polymorphism to influence the proportions of drug-responsive splice variants of SCN1A","volume":"80","author":"Heinzen","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"2021111619233217400_B6","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1365-2125.2008.03203.x","article-title":"Association between SCN1A polymorphism and carbamazepine-resistant epilepsy","volume":"66","author":"Abe","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"key":"2021111619233217400_B7","doi-asserted-by":"publisher","first-page":"5507","DOI":"10.1073\/pnas.0407346102","article-title":"Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin","volume":"102","author":"Tate","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2021111619233217400_B8","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1111\/j.1528-1167.2011.03097.x","article-title":"A functional polymorphism in the SCN1A gene does not influence antiepileptic drug responsiveness in Italian patients with focal epilepsy","volume":"52","author":"Manna","year":"2011","journal-title":"Epilepsia"},{"key":"2021111619233217400_B9","first-page":"67","article-title":"Review and update of the Hong Kong Epilepsy Guideline on status epilepticus","volume":"23","author":"Fung","year":"2017","journal-title":"Hong Kong Med. J."},{"key":"2021111619233217400_B10","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"key":"2021111619233217400_B11","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"2021111619233217400_B12","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"2021111619233217400_B13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.yebeh.2011.02.015","article-title":"Effects of ABCB1 polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy","volume":"21","author":"Meng","year":"2011","journal-title":"Epilepsy Behav."},{"key":"2021111619233217400_B14","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.eplepsyres.2006.10.004","article-title":"The controversial association of ABCB1 polymorphisms in refractory epilepsy: an analysis of multiple SNPs in an Irish population","volume":"73","author":"Shahwan","year":"2007","journal-title":"Epilepsy Res."},{"key":"2021111619233217400_B15","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.braindev.2018.06.003","article-title":"Incidence of childhood epilepsy: a population-based study in rural Japan","volume":"40","author":"Okamoto","year":"2018","journal-title":"Brain Dev."},{"key":"2021111619233217400_B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2018.3.JNS171722","article-title":"An estimation of global volume of surgically treatable epilepsy based on a systematic review and meta-analysis of epilepsy","author":"Vaughan","year":"2018","journal-title":"J. Neurosurg."},{"key":"2021111619233217400_B17","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"2021111619233217400_B18","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20180702","article-title":"The association between rs16917496 T\/C polymorphism of SET8 gene and cancer risk in Asian populations: a meta-analysis","author":"Wei","year":"2018","journal-title":"Biosci. Rep."},{"key":"2021111619233217400_B19","doi-asserted-by":"publisher","first-page":"e0188978","DOI":"10.1371\/journal.pone.0188978","article-title":"Molecular diagnosis of patients with epilepsy and developmental delay using a customized panel of epilepsy genes","volume":"12","author":"Ortega-Moreno","year":"2017","journal-title":"PLoS One"},{"key":"2021111619233217400_B20","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1007\/s00415-017-8512-1","article-title":"Characteristics associated with quality of life among people with drug-resistant epilepsy","volume":"264","author":"Ridsdale","year":"2017","journal-title":"J. Neurol."},{"key":"2021111619233217400_B21","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s12098-014-1533-1","article-title":"Refractory epilepsy in children","volume":"81","author":"Aneja","year":"2014","journal-title":"Indian J. Pediatr."},{"key":"2021111619233217400_B22","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1097\/01.fpc.0000230114.41828.73","article-title":"A common polymorphism in the SCN1A gene associates with phenytoin serum levels at maintenance dose","volume":"16","author":"Tate","year":"2006","journal-title":"Pharmacogenet. Genomics"},{"key":"2021111619233217400_B23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.seizure.2009.12.004","article-title":"Genetic factors associated with drug-resistance of epilepsy: relevance of stratification by patient age and aetiology of epilepsy","volume":"19","author":"Sanchez","year":"2010","journal-title":"Seizure"},{"key":"2021111619233217400_B24","doi-asserted-by":"publisher","first-page":"e0141266","DOI":"10.1371\/journal.pone.0141266","article-title":"Determination of the optimal concentration of valproic acid in patients with epilepsy: a population pharmacokinetic-pharmacodynamic analysis","volume":"10","author":"Nakashima","year":"2015","journal-title":"PLoS One"},{"key":"2021111619233217400_B25","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s40263-015-0281-8","article-title":"Antiepileptic drug treatment in children with epilepsy","volume":"29","author":"Rosati","year":"2015","journal-title":"CNS Drugs"},{"key":"2021111619233217400_B26","doi-asserted-by":"publisher","first-page":"e1007285","DOI":"10.1371\/journal.pgen.1007285","article-title":"Global characterization of copy number variants in epilepsy patients from whole genome sequencing","volume":"14","author":"Monlong","year":"2018","journal-title":"PLoS Genet."},{"key":"2021111619233217400_B27","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1080\/17425255.2018.1473377","article-title":"Clinical reappraisal of the influence of drug-transporter polymorphisms in epilepsy","volume":"14","author":"Orlandi","year":"2018","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"2021111619233217400_B28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1440-1681.2012.05680.x","article-title":"Comprehensive analysis of the association of SCN1A gene polymorphisms with the retention rate of carbamazepine following monotherapy for new-onset focal seizures in the Chinese Han population","volume":"39","author":"Zhou","year":"2012","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"2021111619233217400_B29","doi-asserted-by":"publisher","first-page":"138","DOI":"10.5114\/aoms.2016.59737","article-title":"Association of SCN1A gene polymorphism with antiepileptic drug responsiveness in the population of Thrace, Greece","volume":"13","author":"Angelopoulou","year":"2017","journal-title":"Arch. Med. Sci."},{"key":"2021111619233217400_B30","first-page":"416","article-title":"ABCB1, ABCC2, SCN1A, SCN2A, GABRA1 gene polymorphisms and drug resistant epilepsy in the Chinese Han population","volume":"70","author":"Zhou","year":"2015","journal-title":"Pharmazie"},{"key":"2021111619233217400_B31","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1097\/FPC.0b013e3283117d67","article-title":"Multidrug resistance in epilepsy and polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, and SCN3A: correlation among phenotype, genotype, and mRNA expression","volume":"18","author":"Kwan","year":"2008","journal-title":"Pharmacogenet. Genomics"},{"key":"2021111619233217400_B32","volume-title":"Association study between the Polymorphisms of ABCC2,ABCBl,SCNlA,SCN2A,GABRAl and Drug Resistant Epilepsy in Han Chinese","author":"Cao","year":"2013"},{"key":"2021111619233217400_B33","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.biochi.2013.02.006","article-title":"SCN1AIVS5-91G&gt;A polymorphism is associated with susceptibility to epilepsy but not with drug responsiveness","volume":"95","author":"Kumari","year":"2013","journal-title":"Biochimie"},{"key":"2021111619233217400_B34","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1111\/j.1528-1167.2011.03097.x","article-title":"A functional polymorphism in the SCN1A gene does not influence antiepileptic drug responsiveness in Italian patients with focal epilepsy","volume":"52","author":"Manna","year":"2011","journal-title":"Epilepsia"},{"key":"2021111619233217400_B35","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.2217\/pgs.12.127","article-title":"SCN1A IVS5N+5 polymorphism and response to sodium valproate: a multicenter study","volume":"13","author":"Haerian","year":"2012","journal-title":"Pharmacogenomics"}],"container-title":["Bioscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20181654\/810345\/bsr-2018-1654.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20181654\/810345\/bsr-2018-1654.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T20:17:44Z","timestamp":1637093864000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/bioscirep\/article\/38\/6\/BSR20181654\/98252\/Association-between-SCN1A-polymorphism-rs3812718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,18]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12,21]]}},"URL":"https:\/\/doi.org\/10.1042\/bsr20181654","relation":{},"ISSN":["0144-8463","1573-4935"],"issn-type":[{"value":"0144-8463","type":"print"},{"value":"1573-4935","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,18]]},"article-number":"BSR20181654"}}